¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï ±Øº¹»ç¾÷ °øµ¿ ½ÉÆ÷Áö¾ö : 2022-11-18

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï ±Øº¹»ç¾÷ °øµ¿ ½ÉÆ÷Áö¾ö : 2022-11-18
±³À°ÀÏÀÚ : 2022-11-18
±³À°Àå¼Ò : È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦  
±³À°ÁÖÁ¦ : 2022 ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï ±Øº¹»ç¾÷ °øµ¿ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸  
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  
À̸ÞÀÏ : hematology@kams.or.kr      
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 2Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 14:00~14:15 Standard risk ALL(acute lymphoblastic leukemia)  ÁÖÈñ¿µ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 14:15~14:30 High risk ALL(acute lymphoblastic leukemia)  ÀÌÀç¿í(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 14:30~14:45 Very high risk ALL(acute lymphoblastic leukemia)  È«°æÅÃ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 14:45~15:00 Infant ALL(acute lymphoblastic leukemia)  Çѽ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 15:00~15:15 Relapsed ALL(acute lymphoblastic leukemia)  ±èÇý¸®(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 16:00~16:20 MRD(minimal residual disease) assessment using NGS(next generation sequencing) in pediaric ALL(acute lymphoblastic leukemia)  ÀÌÁö¼ö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 16:20~16:40 linical application of NGS(next generation sequencing) MRD(minimal residual disease) pediatric ALL(acute lymphoblastic leukemia)  È«°æÅÃ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 16:40~17:00 Comprehensive analysis of genomic data for pediatric hematologic malignancies  ±è¸í½Å(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 17:00~17:20 Preparation & Launch of the genome analysis project for pediatric hematologic malignancies in Korea  ±èÇý¸®(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-18 È£ÅÚ¸®º£¶óû´ã 3Ãþ, º£¸£»çÀÌÀ¯È¦ 17:20~18:00 CAR-T cell therapy pediatric ALL(acute lymphoblastic leukemia) reguiring HSCT(hematopoietic stem cell transplantation)  °­ÇüÁø(¼­¿ïÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ¼Ò¾Æû¼Ò³â ±Þ¼º¸²ÇÁ¸ð±¸¹éÇ÷º´¿¬±¸È¸ ÀÌ°ÇÈñ ¼Ò¾Æ¾Ï ±Øº¹»ç¾÷ °øµ¿ ½ÉÆ÷Áö¾ö : 2022-11-18""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 °í·Á´ëÇб³¾È»êº´¿ø ¼ºÇü¿Ü°ú ½ÉÆ÷Áö¾ö : 2022-11-18
´ÙÀ½±Û ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ´ëÀüÁöȸ ¿¬¼ö±³À°(¹«¿ù°æȯÀÚ, Àڱ󻸷Áõ) : 2022-11-18
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 41 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 46 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 48 2024-05-28
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 24 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 27 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 18 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 16 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 18 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 21 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 25 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 20 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 13 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 16 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 7 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 18 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷